✦ LIBER ✦

65 Phase 3 study of ataluren (PTC124®) in nonsense mutation cystic fibrosis (nmCF): baseline data

✍ Scribed by E. Kerem; M. Wilschanski; K. De Boeck; I. Sermet-Gaudelus; S. Constantine; G.L. Elfring; N.L. Miller; J. Barth; T. Ajayi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

WS7.5 Interim results of the phase 3 ope

✍ Kerem, E.; Wilschanski, M.; Sermet-Gaudelus, I.; De Boeck, K.; Accurso, F.J.; Ko 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 61 KB

P3.51 Results of a Phase 2b, dose-rangin

✍ R. Finkel; B. Wong; K. Bushby; A. Reha; G.L. Elfring; L.L. Miller; J. Babiak; M. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

T.P.3.05 Reproducibility and correlation

✍ J. Florence; R.T. Abresch; M. Eagle; E. Gappmaier; A.M. Glanzman; E. Henricson; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB

M.P.3.05 Use of a novel system for gradi

✍ M. Elfring; R.T. Abresch; J. Florence; E. Gappmaier; A.M. Glanzman; E. Henricson 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 43 KB